MetaCap

Gabelli Healthcare & Wellness (GRX) vs Stellus Capital Investment (SCM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Gabelli Healthcare & Wellness (GRX) has outperformed Stellus Capital Investment (SCM) over the past year, gaining 6.3% versus a loss of 48.4%. Over five years, GRX leads with a -23.9% price change compared with -55.6% for SCM. Stellus Capital Investment is the larger company by market cap ($172.5 million vs $144.9 million), about 1.2 times the size.

On valuation, Stellus Capital Investment trades at a lower trailing P/E (10.7x vs 17.5x for Gabelli Healthcare & Wellness). Stellus Capital Investment pays a dividend yielding 21.72%, while Gabelli Healthcare & Wellness does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GRX+6.30%SCM-48.35%
+17%-17%-51%
Nov 21, 20251 yearNov 20, 2026
GRX-25.23%SCM-56.10%
+18%-21%-60%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GRX versus SCM key metrics
MetricGRXSCM
Share price$9.96$6.12
Market cap$144.87M$172.46M
1-day change-1.09%-2.55%
YTD return+3.43%-51.74%
1-year return+6.30%-48.35%
5-year return-23.91%-55.59%
P/E ratio (TTM)17.4710.74
Forward P/E—6.00
EPS (TTM)$0.57$0.57
Dividend yield8.03%21.72%
Annual dividend$0.00$1.33
Net income (latest FY)—$27.05M
52-week high$10.76$13.55
52-week low$8.80$6.12
Distance from 52-week high-7.43%-54.83%
Analyst consensus—hold
Avg. price target upside—+59.31%
Average volume19.40K160.13K
Shares outstanding14.54M28.18M
SectorFinanceFinance
IndustryFinance/Investors ServicesFinance/Investors Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • GRX has outperformed SCM by 54.7 percentage points over the past year.
  • Gabelli Healthcare & Wellness trades at a higher earnings multiple (17.5x vs 10.7x trailing P/E).
  • Stellus Capital Investment offers a meaningfully higher dividend yield (21.72% vs 8.03%).

About Gabelli Healthcare & Wellness

GRX stock →

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC.

Finance · Finance/Investors Services

About Stellus Capital Investment

SCM stock →

Stellus Capital Investment Corporation is a business development company specializing in investments in private middle-market companies. It invests through first lien, second lien, unitranche, and mezzanine debt financing, often with a corresponding equity investment.

Finance · Finance/Investors Services

GRX vs SCM FAQ

Which is bigger, Gabelli Healthcare & Wellness or Stellus Capital Investment?

Stellus Capital Investment (SCM) is larger, with a market capitalization of $172.46M compared with $144.87M for Gabelli Healthcare & Wellness (GRX).

Which stock has performed better over the past year, GRX or SCM?

GRX returned +6.30% over the past 12 months, compared with -48.35% for SCM (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, GRX or SCM?

SCM has the lower trailing P/E at 10.7, versus 17.5 for GRX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Gabelli Healthcare & Wellness or Stellus Capital Investment?

Stellus Capital Investment has the higher yield at 21.72%, compared with 8.03% for Gabelli Healthcare & Wellness.

Are Gabelli Healthcare & Wellness and Stellus Capital Investment in the same industry?

Yes. Both are classified in the Finance/Investors Services industry within the Finance sector.

More comparisons